StockData
Solid Biosciences Inc. logo

Solid Biosciences Inc. (SLDB) stock

SLDBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$6.25−0.19 (-2.95%)

Close on Nov 20, 2026Market cap $670.16MP/E –Yield –

Solid Biosciences gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Solid Biosciences

Solid Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Solid Biosciences figures

See a number that looks wrong?